cas 14347-78-5|| where to buy (R)-2,2-Dimethyl-1,3-dioxolane-4-methanol

Product Name:(R)-2,2-Dimethyl-1,3-dioxolane-4-methanol

IUPAC Name:[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methanol

Packing Unit	Available Stock	Price($)
CM116027-100g	in stock	ƿũȐ
CM116027-500g	in stock	ǜƛƎ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 14347-78-5 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:14347-78-5; Molecular Formula:C6H12O3; Melting Point:-; Smiles Code:OC[C@H]1OC(C)(C)OC1; Density:

: Catalog Number:CM116027; Molecular Weight:132.16; Boiling Point:188.5°C at 760 mmHg; MDL No:MFCD00003213; Storage:Store at 2-8°C.

: Dioxolanes; Dioxolane is a heterocyclic acetal with the formula (CH2)2O2CH2. It is related to tetrahydrofuran by exchanging an oxygen for the CH2 group. The isomer 1,2-dioxolane (in which the two oxygen centers are adjacent) is a peroxide. 1,3-Dioxolane is used as solvent and comonomer in polyacetal. The dioxolane-type and their hydrogenolysis can provide very valuable partially protected building blocks either for oligosaccharide syntheses or sugar transformations.

: Alicyclic Heterocycles; When the ends of the chains are joined together into a ring, cyclic compounds result; such substances often are referred to as carbocyclic or alicyclic compounds. Substitution of one or more of the ring carbon atoms in the molecules of a carbocyclic compound with a heteroatom gives a heterocyclic compound.

: Cenerimod; The S1P1 receptor, a protein that plays a pivotal role in regulating immune response, interacts with S1P, a plasma lipid mediator. Remarkably, S1P regulates an array of physiological phenomena such as angiogenesis, inflammation, immunity, cell motility, and neurotransmitter release.
Enter Cenerimod, a novel, potent, and selective S1P1 receptor modulator featuring unique signaling properties, while notably negating broncho‐ and vasoconstrictor effects. Hence, Cenerimod stands as a promising candidate in the quest for improved S1P1 receptor modulators.